Epidemiology and costs of COPD.

1 Hansen JE, Sun X-G, Wasserman K. Should forced expiratory volume in six seconds replace forced vital capacity to detect airway obstruction? Eur Respir J 2006; 27: 1244–1250. 2 Hansen JE, Sun XG, Wasserman K. Discriminating measures and normal values for expiratory obstruction. Chest 2006; 129: 369–377. 3 Enright P. Does screening for COPD by primary care physicians have potential to cause more harm than good? Chest 2006; 129: 833–834. 4 Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests. Eur Respir J 2005; 26: 948–968. 5 Enright P. Flawed interpretative strategies for lung function tests harm patients. Eur Respir J 2006; 27: 1322–1323. 6 Pelligrino R, Brusasco V, Crapo RO, et al. Flawed interpretative strategies for lung function tests harm patients. Eur Respir J 2006; 27: 1323–1324. 7 Crapo RO, Morris AH, Gardner RM. Reference spirometric values using techniques and equipment that meet ATS standards. Am Rev Respir Dis 1981; 123: 659–664. 8 Knudson RJ, Lebowitz MD, Holberg J, Burrows B. Changes in the normal maximal expiratory flow-volume cure with growth and aging. Am Rev Respir Dis 1983; 127: 725–734. 9 Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from asample of the general US population. Am Rev Respir Crit Care Med 1999:159:179 187.